169 related articles for article (PubMed ID: 1529281)
1. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B
Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281
[TBL] [Abstract][Full Text] [Related]
2. Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids.
Hilliquin P; Houbaba H; Aissa J; Benveniste J; Menkes CJ
Scand J Rheumatol; 1995; 24(3):169-73. PubMed ID: 7777830
[TBL] [Abstract][Full Text] [Related]
3. Presence of paf-acether in rheumatic diseases.
Hilliquin P; Menkes CJ; Laoussadi S; Benveniste J; Arnoux B
Ann Rheum Dis; 1992 Jan; 51(1):29-31. PubMed ID: 1540032
[TBL] [Abstract][Full Text] [Related]
4. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
Dentan C; Lesnik P; Chapman MJ; Ninio E
Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of paf-acether. XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase.
Palmantier R; Dulioust A; Maiza H; Benveniste J; Ninio E
Biochem Biophys Res Commun; 1989 Jul; 162(1):475-82. PubMed ID: 2751666
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
7. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
Ostermann G; Kostner GM; Gries A; Malle E; Till U
Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor acetylhydrolase in human seminal plasma.
Letendre ED; Miron P; Roberts KD; Langlais J
Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
[TBL] [Abstract][Full Text] [Related]
9. Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.
Korth R; Bidault J; Palmantier R; Benveniste J; Ninio E
Lipids; 1993 Mar; 28(3):193-9. PubMed ID: 8464350
[TBL] [Abstract][Full Text] [Related]
10. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia.
Jehle R; Schlame M; Büttner C; Frey B; Sinha P; Rüstow B
Biochim Biophys Acta; 2001 May; 1532(1-2):60-6. PubMed ID: 11420174
[TBL] [Abstract][Full Text] [Related]
12. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
Stafforini DM; McIntyre TM; Carter ME; Prescott SM
J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
[TBL] [Abstract][Full Text] [Related]
13. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia.
Gaylord MS; Smith ZL; Lorch V; Blank ML; Snyder F
Am J Med Sci; 1996 Oct; 312(4):149-54. PubMed ID: 8853062
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor.
Elstad MR; Stafforini DM; McIntyre TM; Prescott SM; Zimmerman GA
J Biol Chem; 1989 May; 264(15):8467-70. PubMed ID: 2722780
[TBL] [Abstract][Full Text] [Related]
15. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory actions of platelet-activating factor: control by PAF acetylhydrolase.
Prescott SM
J Investig Allergol Clin Immunol; 1997; 7(5):416. PubMed ID: 9416565
[No Abstract] [Full Text] [Related]
17. Release of platelet-activating factor in systemic lupus erythematosus.
Tetta C; Bussolino F; Modena V; Montrucchio G; Segoloni G; Pescarmona G; Camussi G
Int Arch Allergy Appl Immunol; 1990; 91(3):244-56. PubMed ID: 2354868
[TBL] [Abstract][Full Text] [Related]
18. PAF and PAF acetylhydrolase in the nervous system.
Hattori M; Aoki J; Arai H; Inoue K
J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):99-102. PubMed ID: 8906551
[TBL] [Abstract][Full Text] [Related]
19. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin.
Hirafuji M; Mencia-Huerta JM; Benveniste J
Biochim Biophys Acta; 1987 Oct; 930(3):359-69. PubMed ID: 2888488
[TBL] [Abstract][Full Text] [Related]
20. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.
Yanoshita R; Kudo I; Ikizawa K; Chang HW; Kobayashi S; Ohno M; Nojima S; Inoue K
J Biochem; 1988 May; 103(5):815-9. PubMed ID: 3182751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
